Barrett & Company’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$195K Buy
882
+657
+292% +$182K 0.05% 170
2026
Q1
$66.5K Hold
225
0.02% 256
2025
Q4
$61.4K Hold
225
0.02% 269
2025
Q3
$60.8K Hold
225
0.02% 272
2025
Q2
$62K Hold
225
0.02% 270
2025
Q1
$59.7K Hold
225
0.03% 245
2024
Q4
$52.3K Hold
225
0.02% 265
2024
Q3
$49.6K Sell
225
-280
-55% -$57.9K 0.02% 266
2024
Q2
$99.2K Buy
505
+1
+0.2% +$207 0.04% 196
2024
Q1
$109K Buy
504
+52
+12% +$10.9K 0.05% 191
2023
Q4
$95.2K Hold
452
0.05% 192
2023
Q3
$90.4K Buy
452
+1
+0.2% +$199 0.05% 187
2023
Q2
$83.6K Hold
451
0.05% 204
2023
Q1
$86.3K Buy
451
+17
+4% +$3.07K 0.05% 194
2022
Q4
$73K Hold
434
0.05% 201
2022
Q3
$73K Buy
+434
New +$85.8K 0.05% 201

Other funds holding CME

Barrett & Company's CME Position: Q2 2026 in Review

Barrett & Company increased its CME Group (CME) stake by 292% in Q2 2026, buying an estimated $182K and bringing the position to 882 shares worth $195K. The position accounts for 0.05% of the portfolio, ranked #170.

Barrett & Company first reported a position in CME in Q3 2022 and has held it in 16 quarters since. 1,707 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Barrett & Company held 882 shares of CME Group worth $195K as of Q2 2026.
  • Barrett & Company bought 657 CME Group shares in Q2 2026, an estimated $182K.
  • CME Group made up 0.05% of Barrett & Company's portfolio in Q2 2026, its #170 holding.
  • Barrett & Company first reported a position in CME Group in Q3 2022 and has held it in 16 quarters since.
  • 1,707 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Barrett & Company's 13F filing for Q2 2026, filed 24 Jul 2026.